ABT - Abbott Labs Common
This page shows which of the focused investors we track hold ABT and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2012 it was held by 8 managers with an aggregate reported value of $326.77M, which is 0.06% of the combined portfolio.
As of Q3 2012, 8 tracked institutional managers held ABT (Abbott Labs Common) with an aggregate reported value of $326.77M — 0.06% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades ABT — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2012
- Ticker
- ABT
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Polen Capital Management - Polen Capital Management | 6.13% | Add +39.8% | 3,735,838 | $256.13M |
| 2 | Stanley Druckenmiller - Duquesne Family Office LLC | 2.51% | - | 665,500 | $45.63M |
| 3 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 0.36% | Reduce -0.2% | 215,022 | $14.74M |
| 4 | Thomas Russo - Gardner Russo & Quinn | 0.10% | Reduce -70.6% | 104,550 | $7.17M |
| 5 | Dodge & Cox - Dodge & Cox | 0.00% | Reduce -0.5% | 38,063 | $2.61M |
| 6 | Jensen Investment Management - Jensen Investment Management | 4.63% | New | 0 | $258.72K |
| 7 | Yacktman Asset Management - Yacktman Asset Management | 0.00% | New | 3,000 | $206K |
| 8 | Valley Forge Capital Management - Valley Forge Capital Management | 0.36% | New | 0 | $30.98K |
Loading holder history for ABT…